Hepatitis C Guidelines From NICE Pave Way For Treatment Of Patients With Mild Disease
This article was originally published in The Pink Sheet Daily
Treatment with peginterferon alfa should cease if first course fails, NICE says.
You may also be interested in...
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4
Company also closes agreement to acquire the majority of capital and voting rights of Swiss drug maker Serono.